Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,169 | 145,200 | 172,790 | 153,158 | 10 |
| Marketable Securities | 148,306 | 37,017 | 12,784 | 36,937 | 0 |
| Receivables | N/A | N/A | N/A | N/A | 160 |
| Other current assets | 3,506 | 2,038 | 2,031 | 541 | 0 |
| TOTAL | $180,981 | $184,255 | $187,605 | $190,636 | $170 |
| Non-Current Assets | |||||
| PPE Net | 578 | 641 | 708 | 774 | N/A |
| Other Non-Current Assets | 1,173 | 1,420 | 1,420 | 2,026 | 0 |
| TOTAL | $1,751 | $2,061 | $2,128 | $2,800 | $N/A |
| Total Assets | $182,732 | $186,316 | $189,733 | $193,436 | $170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,005 | 975 | 1,685 | 2,216 | 1,390 |
| Accrued Expenses | 2,200 | 2,099 | 3,082 | 2,719 | 3,220 |
| Other current liabilities | N/A | N/A | N/A | N/A | 2,970 |
| TOTAL | $18,110 | $18,069 | $19,577 | $20,114 | $8,380 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 14,348 | 14,348 | 14,348 | 14,348 | N/A |
| Other Non-Current Liabilities | 1,168 | 1,414 | 1,413 | 0 | 0 |
| TOTAL | $58,561 | $62,394 | $65,980 | $69,036 | $N/A |
| Total Liabilities | $76,671 | $80,463 | $85,557 | $89,150 | $8,380 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,035 | 6,029 | 6,018 | 6,013 | N/A |
| Common Shares | 42 | 42 | 42 | 42 | 7,830 |
| Retained earnings | -117,272 | -115,960 | -115,926 | -114,102 | -58,280 |
| Other shareholders' equity | -31 | 99 | 195 | 325 | 20 |
| TOTAL | $106,061 | $105,853 | $104,176 | $104,286 | $-8,200 |
| Total Liabilities And Equity | $182,732 | $186,316 | $189,733 | $193,436 | $180 |